Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 2
1970 2
1971 1
1972 1
1973 4
1974 3
1975 2
1976 2
1977 5
1978 6
1979 2
1980 5
1981 8
1982 3
1983 2
1984 7
1985 9
1986 11
1987 10
1988 8
1989 7
1990 15
1991 13
1992 14
1993 19
1994 20
1995 17
1996 21
1997 22
1998 30
1999 36
2000 33
2001 43
2002 48
2003 77
2004 98
2005 98
2006 125
2007 145
2008 140
2009 177
2010 229
2011 269
2012 310
2013 347
2014 340
2015 361
2016 369
2017 335
2018 408
2019 426
2020 509
2021 618
2022 562
2023 502
2024 526
2025 445

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,930 results

Results by year

Filters applied: . Clear all
Page 1
Reply by Authors.
Punjani N, Marinaro JA, Kang C, Gal J, Rippon B, Jotwani R, Weinberg R, Schlegel PN. Punjani N, et al. Among authors: kang c. J Urol. 2024 May;211(5):668. doi: 10.1097/JU.0000000000003908. Epub 2024 Mar 15. J Urol. 2024. PMID: 38488111 No abstract available.
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.
Hyeon DY, Nam D, Shin HJ, Jeong J, Jung E, Cho SY, Shin DH, Ku JL, Baek HJ, Yoo CW, Hong EK, Lim MC, Lee SJ, Bae YK, Kim JK, Bae J, Choi W, Kim SJ, Back S, Kang C, Madar IH, Kim H, Kim S, Kim DK, Kang J, Park GW, Park KS, Shin Y, Kim SS, Jung K, Hwang D, Lee SW, Kim JY. Hyeon DY, et al. Among authors: kang c. Mol Cancer. 2025 Mar 14;24(1):77. doi: 10.1186/s12943-025-02256-3. Mol Cancer. 2025. PMID: 40087745 Free PMC article.
Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Yang Z, Li Z, Zhan Y, Lin Z, Fang Z, Xu X, Lin L, Li H, Lin Z, Kang C, Liang J, Liang S, Li Y, Li S, Yang X, Ye F, Zhong N; Onradivir Trial Recruitment and Medical Monitoring Group. Yang Z, et al. Among authors: kang c. Lancet Infect Dis. 2024 May;24(5):535-545. doi: 10.1016/S1473-3099(23)00743-0. Epub 2024 Feb 5. Lancet Infect Dis. 2024. PMID: 38330975 Clinical Trial.
6,930 results